A Prospective Analysis of the Prognostic Value of Biomarkers (FibroTest) in Patients with Chronic Hepatitis C
Open Access
- 1 October 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 52 (10) , 1887-1896
- https://doi.org/10.1373/clinchem.2006.070961
Abstract
Background: FibroTest, a noninvasive method of measuring biomarkers of liver fibrosis, is an alternative to liver biopsy for determining the severity of chronic hepatitis C virus (HCV) infection. We compared the 5-year prognostic value of the FibroTest with biopsy staging for predicting cirrhosis decompensation and survival in patients with chronic HCV infection.Keywords
This publication has 43 references indexed in Scilit:
- New science-based endpoints to accelerate oncology drug developmentEuropean Journal Of Cancer, 2005
- Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donorscclm, 2004
- Sampling Variability of Liver Fibrosis in Chronic Hepatitis CHepatology, 2003
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis CHepatology, 2003
- Noninvasive Prediction of Fibrosis in Patients With Chronic Hepatitis CHepatology, 2003
- Role of liver biopsy in management of chronic hepatitis C: A systematic reviewHepatology, 2002
- Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive modelHepatology, 2002
- Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosisJournal of Hepatology, 2000
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973